Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dicopeg Junior
- Development stage
- Phase 4
- Lead developer
- Cantabria Labs Difa Cooper
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Oral
01
Overview
Dicopeg Junior is an osmotic laxative containing polyethylene glycol 3350 (macrogol 3350) as its active ingredient. It is specifically formulated for the treatment of chronic and functional constipation in children, with registration for use in infants from 6 months of age. As a non-absorbable polymer, polyethylene glycol 3350 acts by binding water in the intestinal lumen through osmotic pressure. This process prevents water absorption from the stool, resulting in softened fecal matter and increased volume, which stimulates bowel motility and facilitates defecation. The drug is characterized by its high safety profile in pediatrics as it is not metabolized by gut bacteria and is excreted unchanged in the feces, minimizing systemic absorption and associated metabolic side effects.
- Brand names
- Dicopeg Junior
- Other names
- macrogol 3350macrogol3350macrogol-3350polyethylene glycol 3350
Beyond the preview
Go deeper on Dicopeg Junior.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dicopeg Junior.